Regulation of ACAT activity by a cholesterol substrate pool during the progression and regression phases of atherosclerosis: implications for drug discovery.
The regulation of aortic ACAT by a cholesterol substrate pool (CSP) was investigated in a rabbit progression/regression model of dietary-induced atherosclerosis. ACAT activity increased 25-fold during the 10-week progression phase of the study. ACAT activity decreased 8-fold during the 24-week regression phase of the study, however, it was still 14-fold greater than in normal aortas. ACAT activity assayed in the absence vs. the presence of exogenous cholesterol was used as a qualitative measure of the amount of cholesterol in the CSP. The CSP was filled to 28% of capacity in normal aortas, this increased to 75% during the progression phase. By the end of the regression phase, the CSP was filled to 100% of capacity even though serum cholesterol levels had returned to normal. The data are discussed in terms of emerging concepts of intracellular cholesterol trafficking, ACAT inhibitors, and the types of atherosclerotic lesions which may be subject to amelioration by ACAT inhibitors.
Gillies
P J
PJ
Medical Products Department, E.I. duPont de Nemours & Company, Inc., Wilmington, DE 19880-0400.
Robinson
C S
CS
Rathgeb
K A
KA
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001013:Aorta, Thoracic / Q000201:enzymology; D001161:Arteriosclerosis / Q000201:enzymology* / Q000473:pathology; D002784:Cholesterol / Q000097:blood*; D002791:Cholesterol, Dietary / Q000008:administration & dosage*; D005487:Foam Cells / Q000473:pathology; D009131:Muscle, Smooth, Vascular / Q000201:enzymology* / Q000473:pathology; D011817:Rabbits; D002785:Sterol O-Acyltransferase / Q000037:antagonists & inhibitors / Q000097:blood*
D000924:Anticholesteremic Agents; D002791:Cholesterol, Dietary; D002784:Cholesterol; D002785:Sterol O-Acyltransferase